Potassium-driven acid retention may weaken muscle potassium uptake and amplify kidney stress

The train of thought that ends in this hypothesis. Each stage is the reason the next exists. The master question narrows to a goal, the goal to an unknown nobody has closed, the unknown to the hypothesis proposed here. Every step below says what it rests on and what carries it.

What is measured here stands in for what matters, and may not track it.

Does human aging prolong stress through organs amplifying each other, or through shared triggers and different recovery speeds?

The engine's own statement of the hypothesis, in full.

CROSS-DOMAIN TRANSFER, conditional: In older humans with limited renal reserve, potassium-acid interactions could cause harmful renal-muscle feedback after an ordinary meal or a separately evaluated tolerable activity challenge. Increased extracellular potassium is hypothesized to suppress renal ammonium excretion sufficiently to reduce total net acid disposal. The resulting retained acid burden must generate a sufficiently large and timely exposure at skeletal muscle to reduce potassium uptake; the secondary extracellular potassium rise then further impairs renal acid disposal. Urinary ammonium, whole-body retained acid and muscle extracellular exposure are distinct quantities. Every directed effect, its magnitude and its timing remain unverified. Renal elimination and temporary muscle sequestration provide nominally redundant one-out-of-two protection only if either independently accommodates the same load within the same horizon and physiological limits under matched shared hormonal conditions. Under that condition, reciprocal chemistry could make otherwise sufficient protective functions jointly unavailable. If the functions are sequentially necessary, the redundancy interpretation fails while the chemical-loop question remains open. The target is harmful amplification with useful coordination preserved. Preventing repeated reserve loss and slowing human aging remain additional hypotheses, including the possibility that temporary sequestration merely postpones the burden.

Every other hypothesis the engine wrote for the same gap, and the observation that would separate the two.

• Rival 01 of 02

  Liver energy demand from lactate recycling may sustain a costly muscle–liver feedback loop
  What would separate them

  Liver energy demand from lactate recycling may sustain a costly muscle–liver feedback loop predicts: First establish whether a quantitatively important excess-recycling phenotype exists after matched mild activity. Combine complementary glucose and lactate tracers, regional muscle balance and an identifiable non-steady-state carbon model. Account for circulating glucose, glycogen, alternative lactate fates, other glucose sources and compartment exchange. For a defined muscle compartment, lactate-pool change equals local formation plus uptake minus oxidation, other disposal and export; net vascular release equals export minus uptake. Arteriovenous balance alone cannot identify production. Report uncertainty bounds where formation, uptake or disposal cannot be separated. Bound hepatic energetic expenditure using regional or independently validated mechanistic measurements; whole-body calorimetry, hepatic oxygen consumption alone and an ATP concentration alone cannot identify recycling-specific ATP demand. Define Q_H as hepatic ATP-equivalent turnover attributable to the relevant processing over a specified interval, R as a candidate demand-transmitting cardiovascular or endocrine relay, and Z as specified competing substrate, redox or secretory changes with a possible demand-independent action. These are experimental variables requiring identification, not observed pathways. Identify R's origin, muscle target, exposure-response relation, gain and delay. Validate a liver-restricted recycling perturbation and exclude direct muscle exposure to it or its active products. Match glucose concentration and delivery, insulin, oxygen, electrolytes, arterial lactate and independently imposed upstream inputs; independently replay altered substrate trajectories. Then add a demand-versus-collateral-output discrimination. In one experimental series, independently vary Q_H within the relevant hepatic compartment while matching the specified Z trajectories and allowing R to respond. The frozen mechanism predicts a change in R followed by a corresponding change in independently resolved muscle glycolytic production. In a complementary series, vary candidate Z trajectories while Q_H and upstream inputs are matched. A muscle response fully attributable to Z without an independently demonstrated Q_H-to-R effect supports collateral hepatic signaling rather than establishing the frozen mechanism. If Z is itself proposed to be R, first test whether changing Q_H causes its production; subsequent Z add-back at fixed Q_H tests downstream sufficiency only. Never clamp the actual mediator in a test intended to establish intact transmission. A validated restoration of the relevant hepatic demand during continued recycling reduction, at matched competing outputs, should restore R and muscle production if demand is the operative cause. Generic ATP consumption in another compartment, hypoxia, injury or altered ATP concentration does not qualify as equivalent demand restoration. Independent perturbations or a quantitatively identified dissociation must separate the effects; correlated measurements and statistical adjustment alone are insufficient. No qualifying manipulation is supplied. If separation is infeasible, even successful relay blockade and physiological add-back justify only liver-to-muscle signaling, leaving demand dependence unresolved. In separate mediation experiments, relay blockade should remove the transmitted muscle response and physiological R replacement should restore it despite reduced recycling. Independent glucose replacement should fail to restore the loop only if a non-glucose demand-dependent relay closes it; include the replacement's physiological production, delivery, endocrine and other-organ costs in whole-person accounting. A fall in net lactate release with unchanged formation does not confirm the mechanism. Compare complete coupled and uncoupled systems with matched substrates, hormones, oxygen, waste removal, tissue support and local history. Before testing persistence, specify individualized recovery ranges, required duration within those ranges, an observation horizon based on independently measured recovery distributions, and measurements of residual tissue injury and retained states. Estimate directed responses independently and predict held-out challenges. The strong claim additionally predicts a post-input state incompatible with measured stable-decay and local-memory alternatives, and termination of that state after specific return-path interruption. Longer recovery or a positive root of a local fitted model alone is insufficient; finite observation cannot prove indefinite persistence. Under common forcing, hepatic processing may fall while muscle production follows residual injury or upstream activation. Null results constrain only the tested subgroup and window when target engagement, specificity, sensitivity and pathway representation are adequate.

• Rival 02 of 02

  Gut–liver feedback may prolong cortisol exposure by suppressing its breakdown
  What would separate them

  Gut–liver feedback may prolong cortisol exposure by suppressing its breakdown predicts: First separate adrenal secretion, reversible tissue regeneration, binding, distribution, extrahepatic metabolism and irreversible disposal using specialist isotope kinetics, serial free and total cortisol, binding measurements and steroid metabolomics over repeated circadian cycles. Establish identifiability; report bounds when these determinants cannot be separated. Specify whether clearance is referenced to free or total concentration. Establish a hepatic contribution independently through regional or enzyme-pathway measurements. E_H denotes an unidentified candidate hepatic disposal pathway, not an identified enzyme. Before claiming an enzyme-specific defect, identify the enzyme or defined reaction sequence, labeled products, irreversible fate, hepatic contribution and response to participant-range inflammatory exposure. Measure substrate-to-product conversion and candidate enzyme abundance or activity under matched substrate conditions; a changed expression marker alone is insufficient. A validated pathway-specific loss-and-restoration experiment would need to change irreversible disposal as predicted while alternative pathways and tissue viability are characterized. Until these steps identify E_H, the parent remains a conditional pathway-class hypothesis. Next replay participant-measured free-cortisol concentrations, durations and recovery periods in human enteric preparations containing glia and necessary immune cells, distinguishing glial responses from direct immune glucocorticoid suppression. M_G denotes an unidentified liver-active gut output. Determine its cellular source, production rate, molecular identity or explicitly characterized active fraction, transport, binding, degradation and removal, and the resulting hepatic concentration-time profile. Local gut abundance or culture-supernatant concentration cannot substitute for hepatic exposure. If direct hepatic exposure measurements are unavailable, use a prospectively specified transport model with independently constrained parameters and uncertainty bounds. Test whether the supported exposure range overlaps the measured hepatic inhibitory range. Suppression only at higher concentrations demonstrates pharmacological sufficiency, not operation of the human return arm. At fixed free cortisol and non-gut inflammatory inputs, selective gut interruption should increase pathway-resolved hepatic inactivation after direct hepatocyte exposure to the intervention and active products is excluded. Add-back using the supported hepatic exposure profile should restore suppression. This establishes a return arm only if specificity and physiological delivery are adequate. In a separate unclamped condition, the initial clearance improvement should lower free cortisol, reduce gut output and yield additional clearance recovery. Cortisol replacement should remove the exposure-mediated secondary component; the initial direct consequence of gut interruption can remain. Hepatic restoration followed by replacement alone fits a one-way downstream model. Estimate both tissue response functions, mediator transport, cortisol production and disposal, and adrenal feedback with delays. Test whether their independently measured ranges predict a persistent post-stress state and its interruption, versus stable delayed recovery, on new observations. Include compensatory secretion after increased clearance rather than treating it as zero. A persistent state may coexist with negative feedback without requiring that one local positive gain exceed every opposing process; the complete physiological dynamics must determine the outcome. If compensation restores exposure, predict reduced or absent exposure-mediated functional benefit rather than inferring benefit from clearance alone. Fixed apparatus cortisol tests exposure-response behavior only. Null results constrain adequately represented, specifically perturbed pathways within the tested physiological range. Sleep, activity, host defense and the response to a subsequent safe stress require separate assessment.

Which of the figures above have a study behind them, which are the engine's own, and what it would take to refute the hypothesis. This audit never judges the idea.